Related Articles
Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: Implication in NK cell-based adoptive cellular immunotherapy
Chimeric antigen receptor‑natural killer cells: novel insight into immunotherapy for solid tumors (Review)
CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated
Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells
The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma